# XIFAXAN
> **NDA021361** · New Drug Application · Sponsor: SALIX PHARMS · Approved 2004-05-25
## Drug
- **FDA Application Number:** NDA021361
- **Application type:** New Drug Application
- **Brand name:** XIFAXAN
- **Generic name:** RIFAXIMIN
- **Active ingredients:** RIFAXIMIN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SALIX PHARMS
- **Manufacturer:** Salix Pharmaceuticals, Inc.
- **First approval:** 2004-05-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021361)
---
*AI Analytics · CC0 1.0*